Stock Analysis
- Japan
- /
- Healthcare Services
- /
- TSE:3417
Ohki Healthcare HoldingsLtd Third Quarter 2025 Earnings: EPS: JP¥53.58 (vs JP¥18.78 in 3Q 2024)
Ohki Healthcare HoldingsLtd (TSE:3417) Third Quarter 2025 Results
Key Financial Results
- Revenue: JP¥88.6b (up 3.7% from 3Q 2024).
- Net income: JP¥731.0m (up 182% from 3Q 2024).
- Profit margin: 0.8% (up from 0.3% in 3Q 2024). The increase in margin was driven by higher revenue.
- EPS: JP¥53.58 (up from JP¥18.78 in 3Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Ohki Healthcare HoldingsLtd shares are up 2.5% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 3 warning signs for Ohki Healthcare HoldingsLtd you should be aware of, and 1 of them is a bit unpleasant.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:3417
Ohki Healthcare HoldingsLtd
Distributes pharmaceutical products, health foods, dairy products, cosmetics, and daily necessities.